logo

For the Inventor, By the Inventor

Basel, Switzerland

Gottlieb Ryser

USPTO Granted Patents = 18

Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 168(Granted Patents)


Company Filing History:

goldMedal18 out of 4,945 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1976-1987

Loading Chart...
18 patents (USPTO):Explore Patents
1. 4656310 - Substituted triarylphosphonium derivatives (1987-04-07),
2. 4532355 - Substituted triaryl phosphonium derivatives (1985-07-30),
3. 4319048 - Certain 6-(3'-methoxyphenyl) derivatives of 2,4-hexadienal (1982-03-09),
4. 4267382 - 2,6-Dichloro-4-methoxy-5-methyl-benzene aldehydes (1981-05-12),
5. 4225527 - Polyene compounds (1980-09-30),
6. 4224244 - 9-Phenyl 5,6-dimethyl-nona-2,4,6,8 tetraenal or tetraenol derivatives (1980-09-23),
7. 4215215 - 9-Phenyl-nonate traene compounds (1980-07-29),
8. 4187247 - 9-Substituted phenyl-3,7-dimethyl-nona 2,4,6,8-tetraene compounds (1980-02-05),
9. 4169103 - Nonatetraenoic acid derivatives (1979-09-25),
10. 4163103 - Novel derivatives of 9-substituted (1979-07-31),
11. 4139367 - Piperidine salts as plant growth regulants (1979-02-13),
12. 4107190 - Novel compounds of 9-phenyl-3,7-dimethyl-2,4,6,8-nonatetraenamide (1978-08-15),
13. 4105681 - 9-Phenyl 5,6-dimethyl-nona-2,4,6,8-tetraeonic acid compounds (1978-08-08),
14. 4054589 - Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters (1977-10-18),
15. 4021574 - Antidandruff compositions containing 9-(4-lower (1977-05-03),

Title: Inventor Spotlight: Gottlieb Ryser

Introduction

Gottlieb Ryser is a prominent inventor based in Basel, Switzerland, known for his significant contributions to the field of pharmaceuticals. With a total of 18 patents to his name, his work primarily focuses on innovative compounds that have potential applications in cancer treatment.

Latest Patents

Among his recent innovations, Ryser has developed two notable patents for substituted triarylphosphonium derivatives. These novel compounds, specifically the 9-phenyl 5,6-dimethyl-nona-2,4,6,8-tetraenoic acid and its tetraenal or tetraenol derivatives, have shown promise as anti-tumor agents. These patents exemplify Ryser’s commitment to addressing critical health challenges through innovative chemistry.

Career Highlights

Gottlieb Ryser is currently affiliated with Hoffmann-La Roche Inc., a leading global healthcare company that emphasizes research in pharmaceuticals and diagnostics. His career at this esteemed organization has allowed him to contribute to groundbreaking research and development projects.

Collaborations

Ryser has worked alongside esteemed colleagues such as Werner Bollag and Rudolf Ruegg. Their collaboration reflects a synergy of expertise in pharmaceutical research, enhancing the impact of their projects in the field of cancer therapeutics.

Conclusion

Gottlieb Ryser’s innovative spirit and dedication to scientific advancement are showcased through his extensive patent portfolio and collaborative efforts within the pharmaceutical industry. His contributions, particularly in the area of anti-tumor agents, underscore the important intersection of invention and healthcare. As research continues to evolve, Ryser's work will undoubtedly play a crucial role in transforming therapeutic interventions for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…